Kymera Therapeutics, Inc.KYMRNASDAQ
Loading
Interest Income Over TimeStrong
Percentile Rank86
3Y CAGR+79.1%
5Y CAGR+115.1%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+79.1%/yr
Annual compound
5Y CAGR
+115.1%/yr
Recent deceleration
Percentile
P86
Within normal range
vs 5Y Ago
46x
Strong expansion
PeriodValueYoY Change
TTM$38.03M0.0%
2024$38.03M+102.7%
2023$18.76M+183.3%
2022$6.62M+1257.4%
2021$488000.00-40.9%
2020$826000.00-17.8%
2019$1.00M-
2018$0.00-